Evidence map›Paper›PMID 23091630›Full record

ArticlePloS one2012

Housekeeping gene selection advisory: glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and β-actin are targets of miR-644a.

Kavleen Sikand, Jagjit Singh, Jey Sabith Ebron, Girish C Shukla

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 96 citations in OpenAlex.

  1. Article
  2. Article
  3. Green-synthesized ZnO nanoparticles fromFrontiers in plant science · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. miRNA-Based Technologies in Cancer Therapy.Journal of personalized medicine · 2023
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. MicroRNAs as Regulators of Cancer Cell Energy Metabolism.Journal of personalized medicine · 2022
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Kavleen SikandDepartment of Biological, Geological and Environmental Sciences, Cleveland State University, Cleveland, Ohio, United States of America.
Jagjit Singh
Jey Sabith Ebron
Girish C Shukla
Cleveland State University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Results of overexpression or downregulation of a microRNA (miRNA) on its target mRNA expression are often validated by reverse-transcription and quantitative PCR analysis using an appropriate housekeeping gene as an internal control. The possible direct or indirect effects of a miRNA on the expression of housekeeping genes are often overlooked. Among many housekeeping genes, expressions of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and β-actin have been used extensively for normalization of gene expression data. Here, we show that GAPDH and β-actin are direct targets of miR-644a. Our data demonstrate the unsuitability of GAPDH and β-actin as internal controls in miR-644a functional studies and emphasize the need to carefully consider the choice of a reference gene in miRNA experiments.

Indexed as

3' Untranslated RegionsActinsBase PairingBase SequenceCell LineGene Expression RegulationGene OrderGenes, EssentialGlyceraldehyde-3-Phosphate DehydrogenasesHumansMicroRNAsMolecular Sequence DataRNA, MessengerSequence Alignment3' Untranslated RegionsActinsGlyceraldehyde-3-Phosphate DehydrogenasesMicroRNAsMIRN644 microRNA, humanRNA, Messenger

Identifiers

PMID23091630
PMCPMC3472982
OpenAlexW2035963479

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.